Clinical Trial Update: A Phase I/II Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating LBL-034 in patients with relapsed/refractory multiple myeloma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• LBL-034

Snippet

Sponsor: Nanjing Leads Biolabs Co.,Ltd | Conditions: Relapsed/Refractory Multiple Myeloma | Phase 1, Phase 2 | Status: RECRUITING